MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase

Hong-Liang Xia1,1, Yao Lv2,1, Chun-Wei Xu3

  • 1Department of Surgery, Children's Hospital of Soochow University, Soochow University, Suzhou, Jiangsu 215000, China.

Insights

MicroRNAs (miRNAs), specifically miR-513c, are downregulated in neuroblastoma. Restoring miR-513c levels suppresses tumor growth by targeting glutaminase (GLS), offering a potential miRNA-based therapy for this childhood cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a significant pediatric cancer, accounting for 7-10% of childhood cancers and 15% of pediatric cancer deaths.
  • MicroRNAs (miRNAs) are short, noncoding RNAs regulating gene expression, and glutamine metabolism is crucial for tumor cell survival.
  • Targeting glutamine metabolism presents a promising strategy for developing novel anti-cancer agents.

Purpose of the Study:

  • To investigate the role of miR-513c in human neuroblastoma.
  • To determine if miR-513c can suppress neuroblastoma progression.
  • To identify the molecular targets of miR-513c in neuroblastoma.

Main Methods:

  • Comparative analysis of miR-513c expression in neuroblastoma tissues and cell lines versus normal controls.
  • Functional assays to assess the impact of miR-513c overexpression on neuroblastoma cell migration, invasion, and proliferation.
  • Luciferase reporter assays and Western blotting to validate glutaminase (GLS) as a direct target of miR-513c.

Main Results:

  • miR-513c was significantly downregulated in human neuroblastoma tissues and cell lines.
  • Overexpression of miR-513c inhibited neuroblastoma cell migration, invasion, and proliferation.
  • Glutaminase (GLS) was identified as a direct target of miR-513c, and its restoration reversed the suppressive effects of miR-513c.

Conclusions:

  • miR-513c plays a tumor-suppressive role in human neuroblastoma.
  • The miR-513c/GLS axis is a critical regulator of neuroblastoma cell behavior.
  • miR-513c represents a potential therapeutic target for neuroblastoma treatment.